In a 72-18 vote, the US Senate has confirmed Stephen Hahn as the new commissioner of the Food and Drug Administration.
Merck & Co has announced its acquisition of cancer research biotech ArQule in a $2.7 billion deal.
Momenta Pharmaceuticals has agreed to pay $35 million to settle a 2015 class-action suit that claimed that it blocked generics of the blockbuster blood clot drug enoxaparin from coming to market.
The US, Canada and Mexico have signed a new, finalised trade agreement to replace the old North American Free Trade Agreement.
US senators have requested information regarding the national security risks posed by the role of foreign manufacturing, specifically in China, in the US pharmaceutical products supply chain.
McDonald Hopkins has added Erin Conway as counsel to its IP litigation department in Chicago.
Sanofi is to acquire Synthorx, a biotechnology company focused on improving the lives of people suffering from cancer and autoimmune diseases, for $2.5 billion.
US presidential candidate Bernie Sanders has called on the US Patent and Trademark Office to block extensions to two Gilead Sciences patents covering HIV prevention drugs including Descovy.
Treatment Action Group, a US-based organisation focused on research of diseases such as HIV/AIDS and tuberculosis, has applauded an opposition that aims to block Sanofi from patenting a new TB drug in India.
Medtronic, the world’s largest medical devices company, is facing a patent infringement lawsuit over its line of artificial heart valves.